Cadinha & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,500
| Closed | -$245K | – | 97 |
|
|
2022
Q2 | $245K | Hold |
4,500
| – | – | 0.05% | 85 |
|
|
2022
Q1 | $245K | Hold |
4,500
| – | – | 0.04% | 96 |
|
|
2021
Q4 | $248K | Hold |
4,500
| – | – | 0.03% | 106 |
|
|
2021
Q3 | $215K | Hold |
4,500
| – | – | 0.03% | 120 |
|
|
2021
Q2 | $224K | Hold |
4,500
| – | – | 0.03% | 116 |
|
|
2021
Q1 | $201K | Sell |
4,500
-102
| -2% | -$4.63K | 0.03% | 114 |
|
|
2020
Q4 | $212K | Hold |
4,602
| – | – | 0.03% | 112 |
|
|
2020
Q3 | $217K | Sell |
4,602
-120
| -3% | -$6.01K | 0.04% | 99 |
|
|
2020
Q2 | $241K | Buy |
4,722
+120
| +3% | +$6.16K | 0.04% | 88 |
|
|
2020
Q1 | $218K | Hold |
4,602
| – | – | 0.06% | 81 |
|
|
2019
Q4 | $270K | Hold |
4,602
| – | – | 0.04% | 109 |
|
|
2019
Q3 | $246K | Hold |
4,602
| – | – | 0.04% | 106 |
|
|
2019
Q2 | $230K | Hold |
4,602
| – | – | 0.04% | 102 |
|
|
2019
Q1 | $240K | Buy |
4,602
+102
| +2% | +$5.1K | 0.05% | 97 |
|
|
2018
Q4 | $215K | Hold |
4,500
| – | – | 0.05% | 96 |
|
|
2018
Q3 | $226K | Hold |
4,500
| – | – | 0.04% | 121 |
|
|
2018
Q2 | $227K | Hold |
4,500
| – | – | 0.04% | 119 |
|
|
2018
Q1 | $220K | Buy |
+4,500
| New | +$210K | 0.04% | 122 |
|
|
2017
Q4 | – | Sell |
-4,638
| Closed | -$235K | – | 135 |
|
|
2017
Q3 | $235K | Buy |
4,638
+138
| +3% | +$7K | 0.04% | 120 |
|
|
2017
Q2 | $243K | Hold |
4,500
| – | – | 0.04% | 113 |
|
|
2017
Q1 | $237K | Hold |
4,500
| – | – | 0.05% | 114 |
|
|
2016
Q4 | $217K | Hold |
4,500
| – | – | 0.04% | 108 |
|
|
2016
Q3 | $243K | Hold |
4,500
| – | – | 0.05% | 109 |
|
|
2016
Q2 | $244K | Hold |
4,500
| – | – | 0.05% | 105 |
|
|
2016
Q1 | $228K | Hold |
4,500
| – | – | 0.06% | 100 |
|
|
2015
Q4 | $227K | Hold |
4,500
| – | – | 0.05% | 99 |
|
|
2015
Q3 | $216K | Hold |
4,500
| – | – | 0.05% | 98 |
|
|
2015
Q2 | $234K | Hold |
4,500
| – | – | 0.05% | 99 |
|
|
2015
Q1 | $260K | Hold |
4,500
| – | – | 0.05% | 97 |
|
|
2014
Q4 | $240K | Hold |
4,500
| – | – | 0.04% | 102 |
|
|
2014
Q3 | $259K | Hold |
4,500
| – | – | 0.05% | 95 |
|
|
2014
Q2 | $301K | Hold |
4,500
| – | – | 0.05% | 92 |
|
|
2014
Q1 | $301K | Hold |
4,500
| – | – | 0.05% | 86 |
|
|
2013
Q4 | $300K | Hold |
4,500
| – | – | 0.06% | 85 |
|
|
2013
Q3 | $282K | Hold |
4,500
| – | – | 0.06% | 77 |
|
|
2013
Q2 | $281K | Buy |
+4,500
| New | +$286K | 0.06% | 70 |
|
Other funds holding GSK
Cadinha & Co's GSK Position: Q3 2022 in Review
Cadinha & Co sold out of GSK (GSK) in Q3 2022, closing a stake of 4,500 shares — an estimated $245K sold.
Cadinha & Co first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $301K in Q2 2014. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Cadinha & Co reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Cadinha & Co sold 4,500 GSK shares in Q3 2022, an estimated $245K.
- Cadinha & Co first reported a position in GSK in Q2 2013 and held it in 36 quarters.
- Cadinha & Co's GSK position peaked at $301K in Q2 2014.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Cadinha & Co's 13F filing for Q3 2022, filed 21 Oct 2022.